MedPath

Effects of High Intensity Interval Training and Strength Training in Obese

Not Applicable
Conditions
Obesity
Registration Number
NCT02484235
Lead Sponsor
University of Chile
Brief Summary

Obesity is a global health problem since it is associated with many cardiovascular and metabolic diseases, osteoarticular problems and some cancers. That is why it is a priority of the national health policies. Exercise is a mainstay in the treatment, but still the most effective method is sought. The resistance exercise and high intensity intervals (HIIT) have been shown to positively affect the outcome of the disease, increasing the oxidative capacity of the trained subjects. Therefore it is important to look if both together produce greater benefits or otherwise nullify its effects, such as suggested by recent publications in relation to the cellular response to different stimuli such exercise in skeletal muscle. The aim of this study is to evaluate the effectiveness of interventions exercise high intensity intervals, overload and combining them in the oxidative capacity of obese subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Indication of medical supervised exercise
  • BMI of 25-35kg/m2
  • Participate in a 10 session rehabilitation program
Exclusion Criteria
  • Osteomuscular injuries
  • Cardiovascular disease without control
  • Bariatric Surgery
  • High blood pressure without control

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Exercise Test of Vo2 kinetics6 weeks
Secondary Outcome Measures
NameTimeMethod
Exercise test of max Walking Speed6 weeks
Strength test of 10 maximum repetition (10RM)6 weeks

Trial Locations

Locations (1)

Hospital Clinico de la Universidad de Chile

🇨🇱

Santiago, Metropolitana, Chile

Hospital Clinico de la Universidad de Chile
🇨🇱Santiago, Metropolitana, Chile
Ariel Castro
Contact
+56 2 2978 8535
oaic@hcuch.cl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.